home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Collection of Education
/
collectionofeducationcarat1997.iso
/
HEALTH
/
MED9601.ZIP
/
M9610421.TXT
< prev
next >
Wrap
Text File
|
1996-01-30
|
3KB
|
46 lines
Document 0421
DOCN M9610421
TI Inner-city tuberculosis in the USA.
DT 9601
AU McGowan JE Jr; Blumberg HM; Department of Pathology and Laboratory
Medicine, Emory University; School of Medicine, Atlanta, Georgia.
SO J Hosp Infect. 1995 Jun;30 Suppl:282-95. Unique Identifier : AIDSLINE
MED/96035357
AB Tuberculosis (TB) has become more common during the past five years in
several areas of the USA. Occurrence has been facilitated by the
increasing number of patients with concurrent HIV infection, by cases
due to multiple-drug-resistant strains, by incomplete TB therapy among
homeless and non-compliant patients, and by cases in immigrants from
other countries where TB prevalence is high. These features mean that
the major burden of TB today is being borne by inner-city health care
facilities that care for the poor. This is illustrated by data from
Atlanta, Georgia, where a large proportion of the new cases recognized
in the metropolitan area are reported by Grady Memorial Hospital, the
public hospital serving the indigent and working poor of the inner city.
Similar patterns are recognized in the other USA cities where TB has
again become a blight. In view of these epidemiological features,
minimizing inner-city TB will require careful attention to diagnosis and
isolation procedures in the hospital. Engineering changes at hospitals
providing acute care of TB have recently been ordered by the federal
government. These promise to be very expensive, and primarily affect the
public hospitals, which can least afford them. Innovative treatment
programmes are essential, as follow-up after acute care is difficult in
this setting. Directly observed therapy can help, but for some cases the
era of the TB hospital may have returned. Current attention focuses on
legal and ethical issues associated with detaining non-compliant and
recalcitrant patients to complete their therapy. Bacille Calmette Guerin
(BCG) vaccine is not a priority for this setting at this time.(ABSTRACT
TRUNCATED AT 250 WORDS)
DE Antitubercular Agents/THERAPEUTIC USE AIDS-Related Opportunistic
Infections BCG Vaccine Community-Acquired
Infections/*EPIDEMIOLOGY/PREVENTION & CONTROL Cross
Infection/PREVENTION & CONTROL Georgia/EPIDEMIOLOGY Homeless Persons
Hospitals, Public/ECONOMICS Human Patient Compliance
Tuberculosis/*EPIDEMIOLOGY/PREVENTION & CONTROL Tuberculosis,
Multidrug-Resistant/EPIDEMIOLOGY *Urban Population JOURNAL ARTICLE
REVIEW REVIEW, TUTORIAL
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).